CVS HEALTH CORPORATION Assets, Fair Value Disclosure
CVS HEALTH CORPORATION (CVS) had Assets, Fair Value Disclosure of $41.10 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2026-08-05
- 2026-06-30: Assets, Fair Value Disclosure $41.10B.
- 2026-03-31: Assets, Fair Value Disclosure $38.34B.
- 2025-12-31: Assets, Fair Value Disclosure $37.50B.
- 2024-12-31: Assets, Fair Value Disclosure $34.98B.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $41.10B 10-Q · filed 2026-08-05 |
| 2026-03-31 | $38.34B 10-Q · filed 2026-05-06 |
| 2025-12-31 | $37.50B 10-Q · filed 2026-08-05 |
| 2024-12-31 | $34.98B 10-K · filed 2026-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |